Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Effects of Exercise Training

NCT03730610 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-03-02

No results posted yet for this study

Summary

Obesity and insulin resistance are worldwide epidemic and taking a major public health toll. Obesity also increases the risk for cognitive impairment which is also an increasing medical, societal, and economic challenge. The ultimate goal of this proposal is to develop a statistical model to assess systemic cross-talk between brain, peripheral tissues, gut microbiota and glucose metabolism. Integrated with exercise training intervention the results will be utilized to provide disease risk profiling and personalized predictions of exercise training as a drug free treatment for insulin resistance and type 2 diabetes.

Conditions

Interventions

BEHAVIORAL

Exercise training

Subjects are required to exercise four times a week during six months. Exercise training consists of endurance training, resistance training and high-intensity interval training adjusted to subject's fitness level.

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER
  • University of Eastern Finland

    collaborator OTHER
  • Turku University Hospital

    collaborator OTHER_GOV
  • Academy of Finland

    collaborator OTHER
  • Finnish Cultural Foundation

    collaborator OTHER
  • Diabetes Research Foundation, Finland

    collaborator OTHER
  • Juho Vainio Foundation

    collaborator OTHER
  • University of Turku

    lead OTHER

Principal Investigators

  • Jarna Hannukainen, PhD · Turku PET Cente, University of Turku, Finland

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-30
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03730610 on ClinicalTrials.gov